-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Serial Number
Product Name
Quality Standard
Role and Usage
1
Gliclazide
CP2020、BP2025、EP11、JP18
糖尿病治疗及其并发症预防用药
2
Metformin hydrochloride
CP2020、BP2025、EP11、JP18、USP-NF2025
降血糖药
Factory Introduction
Factory Introduction
Factory Introduction
Control room
Control room
Control room
Medicine display
Medicine display
Medicine display
Medicine display
2023 Shandong Province's Second Batch of Technological Innovation Projects -- (Paotaisong, nifedipine)
2023 Shandong Province's first batch of technological innovation projects -- (Furosemide)
2022 Shandong Province's Second Batch of Technological Innovation Projects -- (Qu Pi Bu Tong)
2022 Shandong Province's first batch of technological innovation projects -- (Esmolol hydrochloride)
2021 Shandong Province's Second Batch of Technological Innovation Projects -- (Ruxolitinib Hydrochloride, Propafenone Hydrochloride)
2021 Shandong Province's first batch of technological innovation projects -- (potassium diclofenac)
2020 Shandong Province's first batch of technological innovation projects -- (Clarithromycin lactose acid)
2019 Shandong Province Fourth Batch of Technological Innovation Projects -- (Voglibose)
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline